Design and Stability Evaluation of Active Peptides from Indonesian Echinozoa as Acetylcholinesterase (AChE) Inhibitors for Alzheimer’s Therapy
Abstract
BACKGROUND: Alzheimer’s disease is characterized by cognitive decline resulting from decreased acetylcholine (ACh) levels due to excessive acetylcholinesterase (AChE) activity. Current therapies, such as galantamine, have several side effects. Bioactive peptides derived from marine Echinozoa (sea urchins and sea cucumbers) have emerged as promising therapeutic agents owing to their structural diversity and diverse bioactivities. Previous studies identified peptides from sea cucumbers and sea urchins collected along the southern coast of Gunung Kidul, Yogyakarta (VLCAGDLR, SWIGLK, MNGKKITVRPR, and KTKDLK), which exhibit acetylcholinesterase (AChE) inhibitory activity. However, the therapeutic use of these peptides is challenged by blood–brain barrier (BBB) penetration and stability issues. Therefore, this study was conducted to identify candidate peptides through in silico analysis and to evaluate their stability in phosphate-buffered saline (PBS) as potential AChE inhibitors.
METHODS: Molecular docking was conducted to evaluate peptide binding affinity to the active site. The best candidate peptides were synthesized and tested in vitro for AChE inhibition using a colorimetric method. Stability was assessed in PBS by monitoring aggregation through turbidity and Congo Red assays.
RESULTS: The sea cucumber peptide SWIGLK showed strong binding affinity (–10.2 kcal/mol) and 12.11% inhibition at 0.19 mM, while the sea urchin peptide KTKDLK exhibited –8.2 kcal/mol and 11.50% inhibition at 0.19 mM. Both peptides remained stable in PBS without aggregation for up to 48 h.
CONCLUSION: SWIGLK and KTKDLK demonstrate the most significant AChE inhibitory activity and maintained structural stability, hence supporting their potential as peptide-based candidates for Alzheimer’s therapy.
KEYWORDS: Alzheimer, AChE inhibitor, holothuroidea, echinoidea, bioactive peptide, peptide stability
Full Text:
PDFReferences
Aliffia D, Ramadhani DA, Wasityastuti W, Sari DRT, Kustiati U, Wihadmadyatami H, et al. Ocimum sanctum leaves prevent neuronal cell apoptosis through reduction of caspase-3 and -9 expressions and inhibition of β-amyloid oligomerization. Indones Biomed J. 2023; 15(4): 322-32, CrossRef.
Zvěřová M. Clinical aspects of Alzheimer's disease. Clin Biochem. 2019; 72: 3-6, CrossRef.
Ruangritchankul S, Chantharit P, Srisuma S, Gray LC. Adverse drug reactions of acetylcholinesterase inhibitors in older people living with dementia: A comprehensive literature review. Ther Clin Risk Manag. 2021; 17: 927-49, CrossRef.
Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024; 9(1): 211, CrossRef.
Rosyidah C, Arozal W, Lee HJ, Tjandrawinata RR, Septiana WL. N-Acetylcysteine prevents sleep deprivation-induced memory deficit in juvenile rats through the suppression of BDNF, cortisol, acetylcholine levels, and inflammatory cytokines expressions. Indones Biomed J. 2025; 17(2): 143-53, CrossRef.
Asen ND, Okagu OD, Udenigwe CC, Aluko RE. In vitro inhibition of acetylcholinesterase activity by yellow field pea (Pisum sativum) protein-derived peptides as revealed by kinetics and molecular docking. Front Nutr. 2022; 9: 1021893, CrossRef.
Fakhirah MA, Banowati ND, Nurjanah Y, Nurulaini SN, Athaya S, Muchtaridi M, et al. In silico study of black pepper (Piper nigrum L.) bioactive compounds as acetylcholinesterase (AChE) enzyme inhibitors in Alzheimer's disease. Indones J Biol Pharm. 2023; 3(2): 106-19, CrossRef.
Marín IDG, López RHC, Martínez OA, Padilla-Martínez II, Correa-Basurto J, Rosales-Hernández MC. New compounds from heterocyclic amines scaffold with multitarget inhibitory activity on Aβ aggregation, AChE, and BACE1 in the Alzheimer disease. PLoS One. 2022; 17(6): e0269129, CrossRef.
Nuringtyas TR, Hidayati L, Rohmah Z, Paramita DK, Suparmin A, Prinanda HH, et al. Bioactive peptides from sea cucumbers and sea urchins: Therapeutic roles and mechanistic insights. Trends Sci. 2025; 22(5): 9513, CrossRef.
Wang C, Shao S, Li N, Zhang Z, Zhang H, Liu B. Advances in Alzheimer's disease-associated Aβ therapy based on peptide. Int J Mol Sci. 2023; 24(17): 13110, CrossRef.
Baig MH, Ahmad K, Rabbani G, Choi I. Use of peptides for the management of Alzheimer's disease: Diagnosis and inhibition. Front Aging Neurosci. 2018; 10: 21, CrossRef.
Pardridge WM. Blood-brain barrier and delivery of protein and gene therapeutics to brain. Front Aging Neurosci. 2020;11: 373, CrossRef.
Nagy NS, Helal M, Alsawy ES, Ali MM, Al-Sherif SS, Essawy AE. Paracentrotus lividus sea urchin gonadal extract mitigates neurotoxicity and inflammatory signaling in a rat model of Parkinson's disease. PLoS One. 2024; 19(12): e0315858, CrossRef.
Purohit K, Reddy N, Sunna A. Exploring the potential of bioactive peptides: From natural sources to therapeutics. Int J Mol Sci. 2024; 25(3): 1391, CrossRef.
Sanchis I, Aimaretti F, Lupotti M, Rietmann A, Dias J, Brazzolotto X, et al. Specific Rosetta-based protein-peptide prediction protocol allows the design of novel cholinesterase inhibitor peptides. Bioorg Chem. 2025; 156(1): 108202, CrossRef.
Rossino G, Marchese E, Galli G, Verde F, Finizio M, Serra M, et al. Peptides as therapeutic agents: Challenges and opportunities in the green transition era. Molecules. 2023; 28(20): 7165, CrossRef.
Dalvi H, Bhat A, Iyer A, Sainaga Jyothi VGS, Jain H, Srivastava S, et al. Armamentarium of cryoprotectants in peptide vaccines: Mechanistic insight, challenges, opportunities and future prospects. Int J Pept Res Ther. 2021; 27(4): 2965-82, CrossRef.
Rahmah S, Widiandani T, Ekowati J, Adi Priatna P. Molecular docking and QSAR study of 5-O-acylpinostrobin derivatives as topoisomerase IIα inhibitors. Jurnal Farmasi dan Ilmu Kefarmasian Indonesia. 2024;11(1):120-7, CrossRef.
Reynoso-García MF, Nicolás-Álvarez DE, Tenorio-Barajas AY, Reyes-Chaparro A. Structural bioinformatics applied to acetylcholinesterase enzyme inhibition. Int J Mol Sci. 2025; 26(8): 3781, CrossRef.
Bahtiarsyah AA, Hidayati L, Wijayanti N, Nuringtyas TR. Synergistic activity of Cinnamomum burmannii (Nees & T. Nees) blume and Aquilaria malaccensis Lamk. extracts for antidiabetic study. Indones Biomed J. 2023;15(2):132-40, CrossRef.
Glekas GD, Foster RM, Cates JR, Estrella JA, Wawrzyniak MJ, Rao CV, et al. A PAS domain binds asparagine in the chemotaxis receptor McpB in Bacillus subtilis. J Biol Chem. 2010; 285(3): 1870-8, CrossRef.
Nurjanah D, Fadilah F, Dharmayanti NLPI. Virtual screening of Indonesian herbal compounds with neuraminidase inhibitor activity against N2 influenza virus protein: An in silico study. Mol Cell Biomed Sci. 2024; 8(2): 105-16, CrossRef.
Anggini PW, Amanina SA, Asyura SR, Dion R. In silico study of essential oil of Bambusa vulgaris leaves as an anti beta-lactamase compound. Mol Cell Biomed Sci. 2022; 6(3): 147-54, CrossRef.
Massardi A, Bahry SS, Rahmawati NA, Shabirah CA, Pangastuti A. Bioactive compounds from Penicillium sp. inhibit antiapoptotic Bcl-2, Bcl-XL and Mcl-1: An in silico study. Mol Cell Biomed Sci. 2023; 7(2): 81-9, CrossRef.
Lu Z, lv R, Dong L, Chen D, Lin S. Sea cucumber peptides protect against memory impairment by regulating dopamine/serotonin metabolization and synapse plasticity of mice hippocampus. J Funct Foods. 2023; 108: 105732, CrossRef.
Lin X, Yao M, Lu JH, Wang Y, Yin X, Liang M, et al. Identification of novel oligopeptides from the simulated digestion of sea cucumber (Stichopus japonicus) to alleviate Aβ aggregation progression. J Funct Foods. 2019; 60: 103412, CrossRef.
Lee SR, Pronto JRD, Sarankhuu BE, Ko KS, Rhee BD, Kim N, et al. Acetylcholinesterase inhibitory activity of pigment echinochrome A from sea urchin Scaphechinus mirabilis. Mar Drugs. 2014; 12(6): 3560-73, CrossRef.
Horgan NG, Djurovic-Topalovic A, Ademoye TA, Fortin JS. The aggregation tendencies of the signal peptide regions of prone and not prone to aggregate proteins. Biochem Biophys Reports. 2025; 42: 101980, CrossRef.
Wang J, Liu Z, Zhao S, Zhang Y, Xu T, Li SZ, et al. Aggregation rules of short peptides. JACS Au. 2024; 4(9): 3567-80, CrossRef.
Cimino R, Savioli M, Carrante NF, Placidi E, Garay-Perez H, López-Abad M, et al. Aggregation properties of a therapeutic peptide for rheumatoid arthritis: A spectroscopic and molecular dynamics study. Chem Phys Mater. 2022; 1(1): 62-70, CrossRef.
Rosa E, Diaferia C, De Mello L, Seitsonen J, Hamley IW, Accardo A. Self-assembled aggregates based on cationic amphiphilic peptides: Structural insight. Soft Matter. 2023; 19(25): 4686-96, CrossRef.
Pignataro MF, Herrera MG, Dodero VI. Evaluation of peptide/protein self-assembly and aggregation by spectroscopic methods. Molecules. 2020; 25(20): 4854, CrossRef.
DOI: https://doi.org/10.18585/inabj.v17i5.3837
Copyright (c) 2025 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
